, Tracking Stock Market Picks
Enter Symbol:
Sanofi-aventis Sa (SNY) [hlAlert]

up 17.20 %

Sanofi-aventis Sa (SNY) rated Buy

Posted on: Wednesday,  Jul 18, 2007  9:25 AM ET by HSBC Securities

HSBC Securities rated Buy Sanofi-aventis Sa (NYSE: SNY) on 07/18/2007, when the stock price was $42.73. Since
then, Sanofi-aventis Sa has gained 17.20% as of 01/26/2016's recent price of $50.08.
If you would have followed this HSBC Securities's recommendation on SNY, you would have gained 17.2% of your investment in 3114 days.

Sanofi-Aventis is a pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. The Company's business includes two main activities: pharmaceuticals and human vaccines through sanofi pasteur. In its pharmaceutical activity, Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. On September 1, 2008, Sanofi-Aventis acquired the Australian company, Symbion CP Holdings Pty Ltd (Symbion Consumer). On September 25, 2008, it acquired Acambis plc. In January 2009, the Company sold its French plant of Colomiers to French pharmaceutical company Unither. In April 2009, the Company acquired Mexican generic company, Laboratorios Kendrick.

HSBC has refined and refocused its Global Equities organisation, creating a lean and flexible business model built to meet the needs of global issuers and investors today and in the future. Acknowledging the changing demands of clients, we have also refined our research model, moving away from traditional maintenance to focus on long term, thematic research (a two-year-plus horizon) combined with short term (zero to three months), real-time, actionable ideas both for companies and sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/18/2007 9:25 AM Buy
as of 8/27/2015
1 Week down  -1.26 %
1 Month down  -2.20 %
3 Months down  -1.39 %
1 YTD down  -6.61 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy